Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Holders of 5% or more of CRXT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Clarus Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Clarus Therapeutics Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Clarus Therapeutics Holdings, Inc., newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 20216:34 AM ET | Mizuho Financial Group Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Weiss Asset Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Blue Water Sponsor LLC | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | Lighthouse Investment Partners, LLC | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Clarus Therapeutics Holdings, Inc. shares.
No Form 144 notices for Clarus Therapeutics Holdings, Inc. are on file.